You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The prognostic implications of microscopic satellites in patients with clinical stage I melanoma

P. Leon, J. M. Daly, M. Synnestvedt, D. J. Schultz, D. E. Elder and W. H. Clark Jr
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia.

Controversy exists as to whether microscopic satellites influence prognosis or patterns of progressive disease in patients with clinical stage I melanoma. Fifty patients with clinical stage I melanoma and microscopic satellites were prospectively studied from 1972 to 1984. To allow for complete histopathology assessment, 30 patients with microscopic satellites who were prospectively seen from 1972 to 1979 were matched to a cohort of 77 patients with vertical growth-phase melanoma without microscopic satellites according to six attributes. The matched cohort study showed that the presence of microscopic satellites appeared to be associated with increased local regional cutaneous and regional nodal disease and a significantly decreased actuarial disease-free survival. A Cox multivariate regression analysis that involved 384 patients with vertical growth-phase clinical stage I melanoma showed that the presence of microscopic satellites independently predicted a poorer disease-free survival and overall survival. Therefore, this study demonstrated that the presence of microscopic satellites correlated with a significantly decreased survival.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Case 2-2007 -- A 49-Year-Old Woman with a Pigmented Lesion on the Arm
Thompson et al.
NEJM 2007;356:285-292.
FULL TEXT  

Factors Predicting the Risk of In-Transit Recurrence After Sentinel Lymphonodectomy in Patients With Cutaneous Malignant Melanoma
Kretschmer et al.
Ann. Surg. Oncol. 2006;13:1105-1112.
ABSTRACT | FULL TEXT  

Predictors and Natural History of In-Transit Melanoma After Sentinel Lymphadenectomy
Pawlik et al.
Ann. Surg. Oncol. 2005;12:587-596.
ABSTRACT | FULL TEXT  

The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes
Pawlik et al.
JCO 2005;23:4588-4590.
FULL TEXT  

The Role of Microsatellites as a Prognostic Factor in Primary Malignant Melanoma
Shaikh et al.
Arch Dermatol 2005;141:739-742.
ABSTRACT | FULL TEXT  

Implications of Microscopic Satellites of the Primary and Extracapsular Lymph Node Spread in Patients With High-Risk Melanoma: Pathologic Corollary of Eastern Cooperative Oncology Group Trial E1690
Rao et al.
JCO 2002;20:2053-2057.
ABSTRACT | FULL TEXT  

Reply to the article "The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group", by D. J. Ruiter et al. (Ann Oncol 2001; 12: 9-11)
Balch and Mihm
Ann Oncol 2002;13:175-176.
FULL TEXT  

Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch et al.
JCO 2001;19:3635-3648.
ABSTRACT | FULL TEXT  

Best practice No 162 The histological reporting of melanoma
Calonje
J. Clin. Pathol. 2000;53:587-590.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.